Tenon Medical (NASDAQ:TNON) Major Shareholder Sells $364,635.92 in Stock

Tenon Medical, Inc. (NASDAQ:TNON) major shareholder Financial Lp Hrt sold 65,582 shares of the firm’s stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $5.56, for a total value of $364,635.92. Following the transaction, the insider owned 15,839 shares of the company’s stock, valued at $88,064.84. The trade was a 80.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Wednesday, September 9th, Financial Lp Hrt sold 60,343 shares of Tenon Medical stock. The shares were sold at an average price of $2.88, for a total transaction of $173,787.84.
• On Thursday, September 10th, Financial Lp Hrt bought 67,925 shares of Tenon Medical stock. The stock was purchased at an average cost of $3.63 per share, with a total value of $246,567.75.
• On Wednesday, September 9th, Financial Lp Hrt bought 39,508 shares of Tenon Medical stock. The stock was purchased at an average price of $3.40 per share, for a total transaction of $134,327.20.
• On Tuesday, September 8th, Financial Lp Hrt purchased 707 shares of Tenon Medical stock. The shares were purchased at an average price of $3.34 per share, for a total transaction of $2,361.38.
• On Friday, September 4th, Financial Lp Hrt sold 1,506 shares of Tenon Medical stock. The stock was sold at an average price of $3.70, for a total transaction of $5,572.20.
• On Thursday, September 3rd, Financial Lp Hrt acquired 1,658 shares of Tenon Medical stock. The stock was acquired at an average cost of $3.98 per share, for a total transaction of $6,598.84.
• On Wednesday, September 2nd, Financial Lp Hrt sold 450 shares of Tenon Medical stock. The shares were sold at an average price of $4.53, for a total value of $2,038.50.
• On Tuesday, September 1st, Financial Lp Hrt purchased 1,790 shares of Tenon Medical stock. The stock was acquired at an average price of $4.57 per share, with a total value of $8,180.30.
• On Monday, August 31st, Financial Lp Hrt sold 1,276 shares of Tenon Medical stock. The shares were sold at an average price of $4.66, for a total value of $5,946.16.
• On Friday, August 28th, Financial Lp Hrt sold 7,023 shares of Tenon Medical stock. The stock was sold at an average price of $7.32, for a total value of $51,408.36.

Tenon Medical Stock Up 9.4%

TNON traded up $0.50 during midday trading on Friday, hitting $5.80. 102,445,288 shares of the company traded hands, compared to its average volume of 1,879,857. The company’s 50-day moving average is $6.30 and its 200 day moving average is $18.21. The firm has a market capitalization of $3.88 million, a PE ratio of -0.13 and a beta of 1.36. Tenon Medical, Inc. has a 52 week low of $2.40 and a 52 week high of $50.40.

Tenon Medical (NASDAQ:TNON) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($12.35) earnings per share for the quarter, missing analysts’ consensus estimates of ($8.40) by ($3.95). Tenon Medical had a negative net margin of 257.85% and a negative return on equity of 907.60%. The company had revenue of $1.28 million for the quarter, compared to the consensus estimate of $1.54 million.

More Tenon Medical News

Here are the key news stories impacting Tenon Medical this week:

• Positive Sentiment: Convertible debt repayment supports the stock: Tenon completed repayment of its convertible debt, an action that may reduce financing risk, eliminate potential future conversion-related dilution, and improve investor sentiment. Tenon Medical Completes Repayment of Convertible Debt
• Neutral Sentiment: Warrant exercise raises cash but creates dilution: An institutional investor agreed to exercise warrants for 572,179 common shares, generating approximately $2.87 million in gross proceeds for Tenon. The investor will also receive new warrants to purchase up to 858,269 additional shares at $5.02 per share. The capital infusion could strengthen liquidity, but the newly issued shares and warrants increase potential dilution. Tenon Medical Announces Warrant Inducement
• Neutral Sentiment: Trading interruptions highlight extreme volatility: TNON experienced multiple LULD pauses during September 11, indicating rapid price movements and unusually heavy speculative trading. These pauses can magnify both gains and losses and may limit near-term liquidity.
• Neutral Sentiment: Short-interest data is inconsistent: One report showed short interest rising to 130,094 shares as of August 31, while a later entry reported zero shares as of September 10. The conflicting figures make the data unreliable, although elevated short interest could contribute to squeeze-driven buying if accurately reported.

Institutional Trading of Tenon Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Jane Street Group LLC purchased a new position in shares of Tenon Medical during the 1st quarter valued at about $29,000. Geode Capital Management LLC increased its stake in shares of Tenon Medical by 34.6% in the fourth quarter. Geode Capital Management LLC now owns 66,640 shares of the company’s stock worth $63,000 after purchasing an additional 17,137 shares in the last quarter. Finally, DRW Securities LLC bought a new stake in shares of Tenon Medical during the 4th quarter valued at $98,000. Hedge funds and other institutional investors own 22.74% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Wall Street Zen raised Tenon Medical to a “hold” rating in a research report on Saturday, August 29th. Weiss Ratings reissued a “sell (e+)” rating on shares of Tenon Medical in a report on Friday, July 17th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold”.

About Tenon Medical

Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.

Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.